Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pivot Pharmaceuticals Inc (PVOTF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 39,506
  • Shares Outstanding, K 79,170
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,280 K
  • 36-Month Beta -5.01
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.00
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.01
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 12/08/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3800 +31.58%
on 10/23/17
0.6000 -16.67%
on 11/22/17
+0.0100 (+2.04%)
since 10/20/17
3-Month
0.0915 +446.45%
on 09/07/17
0.6000 -16.67%
on 11/22/17
+0.3526 (+239.21%)
since 08/21/17
52-Week
0.0212 +2,258.49%
on 11/25/16
0.6000 -16.67%
on 11/22/17
+0.4000 (+400.00%)
since 11/18/16

Most Recent Stories

More News
Pivot Pharmaceuticals Receives Conditional Approval for CSE

PVOTF : 0.5000 (+0.20%)
Pivot Pharmaceuticals Receives Conditional Approval for CSE Listing

VANCOUVER, BC / ACCESSWIRE / November 20, 2017 / Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) ("Pivot" or the "Company"), an emerging biopharmaceutical company engaged in the development and commercialization...

PVOTF : 0.5000 (+0.20%)
Pivot Pharma Focuses on Cannabinoid Delivery -- CFN Media

SEATTLE, WA--(Marketwired - Nov 14, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing the...

PVOTF : 0.5000 (+0.20%)
Pivot Pharma Licenses Thrudermic Transdermal Nanotechnology and Expands Scientific Advisory Board

Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) ("Pivot" or the "Company") is pleased to announce the signing of a Binding Letter of Intent with Thrudermic, LLC, a privately held North Carolina company, to acquire...

PVOTF : 0.5000 (+0.20%)
Pivot Pharma Licenses Thrudermic Transdermal Nanotechnology and Expands Scientific Advisory Board

Dr. Joseph Borovsky and Dr. Leonid Lurya Appointed to Scientific Advisory Board

PVOTF : 0.5000 (+0.20%)
Pivot Pharma Licenses Thrudermic Transdermal Nanotechnology and Expands Scientific Advisory Board

Dr. Joseph Borovsky and Dr. Leonid Lurya Appointed to Scientific Advisory Board

PVOTF : 0.5000 (+0.20%)
Pivot Pharma Executes Binding Letter of Intent to Acquire ACI Foods Inc.

New acquisition generates annual revenue of CAD $2M from hemp-based product sales

PVOTF : 0.5000 (+0.20%)
Pivot Pharma Executes Binding Letter of Intent to Acquire ACI Foods Inc.

New acquisition generates annual revenue of CAD $2M from hemp-based product sales

PVOTF : 0.5000 (+0.20%)
The Biggest Problem Facing Cannabinoid Therapies and the Company That is Doubling Down on Solutions -- CFN Media

SEATTLE, WA--(Marketwired - Oct 2, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing Pivot...

PVOTF : 0.5000 (+0.20%)
The Biggest Problem Facing Cannabinoid Therapies and the Company That is Doubling Down on Solutions -- CFN Media

SEATTLE, WA--(Marketwired - Oct 2, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing Pivot...

PVOTF : 0.5000 (+0.20%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Key Turning Points

2nd Resistance Point 0.5137
1st Resistance Point 0.5063
Last Price 0.5000
1st Support Level 0.4953
2nd Support Level 0.4917

See More

52-Week High 0.6000
Last Price 0.5000
Fibonacci 61.8% 0.3789
Fibonacci 50% 0.3106
Fibonacci 38.2% 0.2423
52-Week Low 0.0212

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart